Affymetrix, Partners HealthCare collaborate
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firm inks three-year translational research agreement with Partners managed care organization to develop microassay-based diagnostics for newborn hearing loss, autism, hypertrophic cardiomyopathy and other conditions. Partners is an integrated healthcare delivery system comprising Brigham & Women's Hospital and Massachusetts General in Boston. Partners' researchers at Harvard Medical School will create and validate the microarray tests in Clinical Laboratory Improvement Amendments-regulated labs. Affymetrix' Translational Medicine Program develops molecular signatures to create custom-designed microarray products that help researchers diagnose and tailor treatments for individual patients...
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.